Literature DB >> 24509915

Left coronary artery occlusion caused by a large thrombus on the left coronary cusp in a patient with a continuous-flow ventricular assist device.

Seiko Nakajima1, Osamu Seguchi, Yoshihiro Murata, Tomoyuki Fujita, Hiroki Hata, Takafumi Yamane, Michinari Hieda, Takuya Watanabe, Takuma Sato, Haruki Sunami, Masanobu Yanase, Junjiro Kobayashi, Takeshi Nakatani.   

Abstract

Despite continual improvements in ventricular assist device (VAD) therapy, various clinical issues are emerging. Importantly, various types of thromboembolic complications have been reported to date. Recently, we encountered a rare continuous-flow VAD-related thromboembolic event that resulted in acute myocardial infarction. A 26-year-old female who just underwent HeartMate II(®) VAD implantation suddenly developed widespread anterolateral myocardial infarction on postoperative day 16. Echocardiography and aortography revealed a large thrombus on the left coronary cusp of the aortic valve that almost completely occluded the left coronary ostium. After VAD implantation, her aortic valve did not open, even at relatively low pump speeds; this was thought to be one of the causes for thrombus formation. Continuous suction of blood from the left ventricle and non-pulsatile flow into the ascending aorta resulted in a continuously closed aortic valve and stagnation of blood in the coronary cusp. Furthermore, both small body size (body surface area <1.3 m(2)) and postoperative right ventricular failure may have exacerbated blood stagnation and thrombus formation in this patient. We should have adjusted the anticoagulation and antiplatelet therapy protocols based on the patient's condition. She underwent off-pump coronary artery bypass surgery and remained in clinically stable condition afterwards.

Entities:  

Mesh:

Year:  2014        PMID: 24509915     DOI: 10.1007/s10047-014-0758-0

Source DB:  PubMed          Journal:  J Artif Organs        ISSN: 1434-7229            Impact factor:   1.731


  10 in total

1.  Acquired von Willebrand syndrome in continuous-flow ventricular assist device recipients.

Authors:  Sheri Crow; Dong Chen; Carmelo Milano; William Thomas; Lyle Joyce; Valentino Piacentino; Riti Sharma; Jogin Wu; Gowthami Arepally; Dawn Bowles; Joseph Rogers; Nestor Villamizar-Ortiz
Journal:  Ann Thorac Surg       Date:  2010-10       Impact factor: 4.330

2.  Post-operative heparin may not be required for transitioning patients with a HeartMate II left ventricular assist system to long-term warfarin therapy.

Authors:  Mark S Slaughter; Yoshifumi Naka; Ranjit John; Andrew Boyle; John V Conte; Stuart D Russell; Keith D Aaronson; Kartik S Sundareswaran; David J Farrar; Francis D Pagani
Journal:  J Heart Lung Transplant       Date:  2010-04-18       Impact factor: 10.247

3.  Aortic root and valve thrombosis after implantation of a left ventricular assist device.

Authors:  Benjamin H Freed; Valluvan Jeevanandam; Neeraj Jolly
Journal:  J Invasive Cardiol       Date:  2011-04       Impact factor: 2.022

4.  Extended mechanical circulatory support with a continuous-flow rotary left ventricular assist device.

Authors:  Francis D Pagani; Leslie W Miller; Stuart D Russell; Keith D Aaronson; Ranjit John; Andrew J Boyle; John V Conte; Roberta C Bogaev; Thomas E MacGillivray; Yoshifumi Naka; Donna Mancini; H Todd Massey; Leway Chen; Charles T Klodell; Juan M Aranda; Nader Moazami; Gregory A Ewald; David J Farrar; O Howard Frazier
Journal:  J Am Coll Cardiol       Date:  2009-07-21       Impact factor: 24.094

5.  Low thromboembolism and pump thrombosis with the HeartMate II left ventricular assist device: analysis of outpatient anti-coagulation.

Authors:  Andrew J Boyle; Stuart D Russell; Jeffrey J Teuteberg; Mark S Slaughter; Nader Moazami; Francis D Pagani; O Howard Frazier; Gerald Heatley; David J Farrar; Ranjit John
Journal:  J Heart Lung Transplant       Date:  2009-09       Impact factor: 10.247

6.  Advanced heart failure treated with continuous-flow left ventricular assist device.

Authors:  Mark S Slaughter; Joseph G Rogers; Carmelo A Milano; Stuart D Russell; John V Conte; David Feldman; Benjamin Sun; Antone J Tatooles; Reynolds M Delgado; James W Long; Thomas C Wozniak; Waqas Ghumman; David J Farrar; O Howard Frazier
Journal:  N Engl J Med       Date:  2009-11-17       Impact factor: 91.245

7.  Fifth INTERMACS annual report: risk factor analysis from more than 6,000 mechanical circulatory support patients.

Authors:  James K Kirklin; David C Naftel; Robert L Kormos; Lynne W Stevenson; Francis D Pagani; Marissa A Miller; J T Baldwin; J Timothy Baldwin; James B Young
Journal:  J Heart Lung Transplant       Date:  2013-02       Impact factor: 10.247

8.  Aortic valve closure for rapidly deteriorated aortic insufficiency after continuous flow left ventricular assist device implantation.

Authors:  Tomoyuki Fujita; Junjiro Kobayashi; Hiroki Hata; Osamu Seguchi; Takuma Sato; Masanobu Yanase; Yoshihiro Murata; Haruki Sunami; Takeshi Nakatani
Journal:  J Artif Organs       Date:  2012-09-18       Impact factor: 1.731

9.  Aortic valve noncoronary cusp thrombosis after implantation of a nonpulsatile, continuous-flow pump.

Authors:  Zumrut T Demirozu; O H Frazier
Journal:  Tex Heart Inst J       Date:  2012

10.  Low thromboembolic risk for patients with the Heartmate II left ventricular assist device.

Authors:  Ranjit John; Forum Kamdar; Kenneth Liao; Monica Colvin-Adams; Leslie Miller; Lyle Joyce; Andrew Boyle
Journal:  J Thorac Cardiovasc Surg       Date:  2008-09-14       Impact factor: 5.209

  10 in total
  2 in total

1.  Journal of Artificial Organs 2014: the year in review.

Authors:  Y Sawa; K Matsuda; E Tatsumi; G Matsumiya; T Abe; K Fukunaga; A Kishida; K Kokubo; T Masuzawa; A Myoui; M Nishimura; T Nishimura; T Nishinaka; E Okamoto; S Tokunaga; T Tomo; T Tsukiya; Y Yagi; T Yamaoka
Journal:  J Artif Organs       Date:  2015-02-21       Impact factor: 1.731

Review 2.  Medical Management of Pump-Related Thrombosis in Patients with Continuous-Flow Left Ventricular Assist Devices: A Systematic Review and Meta-Analysis.

Authors:  Geetanjali Dang; Narendranath Epperla; Vijayadershan Muppidi; Natasha Sahr; Amy Pan; Pippa Simpson; Lisa Baumann Kreuziger
Journal:  ASAIO J       Date:  2017 Jul/Aug       Impact factor: 2.872

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.